Kuwait Adeno Associated Virus Vector Manufacturing Market Size & Outlook

The adeno associated virus vector manufacturing market in Kuwait is expected to reach a projected revenue of US$ 3.1 million by 2030. A compound annual growth rate of 8.2% is expected of Kuwait adeno associated virus vector manufacturing market from 2025 to 2030.
Revenue, 2024 (US$M)
$1.9
Forecast, 2030 (US$M)
$3.1
CAGR, 2025 - 2030
8.2%
Report Coverage
Kuwait

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait adeno associated virus vector manufacturing market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Kuwait adeno associated virus vector manufacturing market highlights

  • The Kuwait adeno associated virus vector manufacturing market generated a revenue of USD 1.9 million in 2024 and is expected to reach USD 3.1 million by 2030.
  • The Kuwait market is expected to grow at a CAGR of 8.2% from 2025 to 2030.
  • In terms of segment, clinical was the largest revenue generating scale of operations in 2024.
  • Commercial is the most lucrative scale of operations segment registering the fastest growth during the forecast period.


Adeno associated virus vector manufacturing market data book summary

Market revenue in 2024USD 1.9 million
Market revenue in 2030USD 3.1 million
Growth rate8.2% (CAGR from 2025 to 2030)
Largest segmentClinical
Fastest growing segmentCommercial
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationClinical, Preclinical, Commercial
Key market players worldwideRoche, Wuxi AppTec Co Ltd, Pfizer Inc, Astellas Pharma Inc, Lifespan, Genscript Biotech Corp Class H, Biomarin Pharmaceutical Inc, Oxford Biomedical Research, Sarepta Therapeutics Inc, YposKesi


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.2% of the global adeno associated virus vector manufacturing market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia adeno associated virus vector manufacturing market is projected to lead the regional market in terms of revenue in 2030.
  • UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 8.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Adeno Associated Virus Vector Manufacturing Market Companies

Name Profile # Employees HQ Website
YposKesi View profile 101-250 Corbeil-essonnes, Ile-de-France, France, Europe http://www.yposkesi.com
Oxford Biomedical Research View profile 11-50 Rochester Hills, Michigan, United States, North America https://www.oxfordbiomed.com/
Biomarin Pharmaceutical Inc View profile 3401 770 Lindaro Street, San Rafael, CA, United States, 94901 https://www.biomarin.com
Sarepta Therapeutics Inc View profile 1314 215 First Street, Suite 415, Cambridge, MA, United States, 02142 https://www.sarepta.com
Astellas Pharma Inc View profile 14484 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 http://www.astellas.com
Genscript Biotech Corp Class H View profile 6937 No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 https://www.genscript.com
Roche View profile 10001+ Basel, Basel-Stadt, Switzerland, Europe http://www.roche.com
Wuxi AppTec Co Ltd View profile 41116 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 https://www.wuxiapptec.com
Lifespan View profile 10001+ Providence, Rhode Island, United States, North America https://www.lifespan.org/
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com

Kuwait adeno associated virus vector manufacturing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to adeno associated virus vector manufacturing market will help companies and investors design strategic landscapes.


Clinical was the largest segment with a revenue share of 52.63% in 2024. Horizon Databook has segmented the Kuwait adeno associated virus vector manufacturing market based on clinical, preclinical, commercial covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Kuwait adeno associated virus vector manufacturing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Kuwait adeno associated virus vector manufacturing market databook

  • Our clientele includes a mix of adeno associated virus vector manufacturing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait adeno associated virus vector manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait adeno associated virus vector manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Kuwait adeno associated virus vector manufacturing market size, by scale of operations, 2018-2030 (US$M)

Kuwait Adeno Associated Virus Vector Manufacturing Market Outlook Share, 2024 & 2030 (US$M)

Kuwait adeno associated virus vector manufacturing market size, by scale of operations, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online